SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-150240
Filing Date
2021-05-04
Accepted
2021-05-04 17:15:03
Documents
14
Period of Report
2021-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d104062d8k.htm   iXBRL 8-K 34774
2 EX-1.1 d104062dex11.htm EX-1.1 208695
3 EX-5.1 d104062dex51.htm EX-5.1 4368
  Complete submission text file 0001193125-21-150240.txt   430613

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvta-20210430.xsd EX-101.SCH 3092
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20210430_lab.xml EX-101.LAB 17372
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20210430_pre.xml EX-101.PRE 10967
7 EXTRACTED XBRL INSTANCE DOCUMENT d104062d8k_htm.xml XML 3273
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 21889797
SIC: 8071 Services-Medical Laboratories